Mark Duerkop
Industry 4.0: Where are we, and how to accelerate the transition?
Strategies to faster implement pharma 4.0 concepts in biopharmaceutical industry using advanced data storing platform and hybrid modeling
Most recent blog updates
Are you interested in a summary of our latest research results, scientific statements, a report about an event or simply about our team excursions? Read more about all these topics in our most recent posts.
Search
Mark Duerkop
- Jul 28, 2021
- 2 min
Antleron and Novasign to join forces in ATMP Modeling
Antleron and Novasign announce their collaboration in developing advanced process modeling strategies for ATMP manufacturing.
110 views0 comments
Benjamin Bayer
- Oct 15, 2020
- 4 min
Novasign Soft Sensing Technology at Siemens’ LivingLab
Soft Sensor implementation togheter with Siemens enables customers to better understand, monitor and control the bioprocess(development).
230 views0 comments
Benjamin Bayer
- Apr 3, 2020
- 3 min
COVID-19: An example of why we need robust and fast process development
The current worldwide situation regarding the COVID-19 pandemic has shown all of us how vulnerable our daily life can be. In the case of...
313 views1 comment
Mark Duerkop
- Mar 18, 2020
- 2 min
COVID-19, home office and a new toolbox release
To Speedup Bioprocess Development Novasign just released a new version of a powerful hybrid modeling toolbox during home office and COVID19
247 views0 comments
Maximilian Krippl
- Oct 18, 2019
- 2 min
The Hybrid Modeling Summer School 2019
From the 25th to the 27th of September, Novasign co-hosted the 4th hybrid modeling summer school in Lisbon, Portugal. After a very...
217 views0 comments
Mark Duerkop
- Aug 27, 2019
- 2 min
Beyond static process descriptions
Have you ever used DoE tools to describe your upstream bioprocess? If so you most definitely have missed the essentials: the dynamics!
149 views0 comments
Mark Duerkop
- Mar 27, 2019
- 2 min
Bioprocessing Europe Lisbon
Last week we have been to Bioprocessing Europe in Lisbon. The conference was organized in a brought manner, offering both, an up- and...
145 views0 comments
Mark Duerkop
- Nov 7, 2018
- 3 min
Reducing the costs of biopharmaceuticals: a bioprocess development approach
In 2018 the generated revenue by biopharmaceuticals is estimated to be approximately 200 b$! Although this is an incredibly high number,...
175 views1 comment
Mark Duerkop
- Aug 8, 2018
- 1 min
Best talk @10th ÖGMBT Annual Meeting
From the 17th to the 20th of September, the 10th ÖGMBT Annual Meeting took place in Vienna. Over 450 participants including employees...
108 views0 comments